Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-19T12:24:52.452Z Has data issue: false hasContentIssue false
  • English
  • Français

The Role of Media and Communication in Improving the Use of Drugs and Other Technologies

Published online by Cambridge University Press:  10 March 2009

Chitr Sitthi-amorn  and
Jintana Ngamvithayapongse
Chitr Sitthi-amorn
Affiliation:
Chulalongkorn University
Jintana Ngamvithayapongse
Affiliation:
Chulalongkorn University
Get access Rights & Permissions [Opens in a new window]

Abstract

Policy makers, health care providers, and the general public need valid information about the benefits and harmful effects of drugs and technologies to be able to make rational choices in their acquisition, distribution, and use. Effective communication is important for quality choices of drugs and other technologies. In effective communication, the choice of messages and media must correspond to the culture and beliefs of the target groups to make them comprehend and adopt the conclusions. Messages must be presented on a regular basis. Most regulatory agencies do not have enough resources to mount effective communication programs. Private advertising agencies and other stakeholders have definite roles. Valid knowledge must be the basis of dialogues to reduce emotional disputes among various benefit groups in society.

Type
Special Section: The Consumer And Technology
Information
International Journal of Technology Assessment in Health Care , Volume 14 , Issue 1 , Winter 1998 , pp. 71 - 80
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Avorn, J., & Soumerai, S. B.Improving drug-therapy decision through educational outreach. New England Journal of Medicine, 1983, 308, 389–402.Google Scholar
2.Battisa, R. N.Lessons from eight countries. Health Policy, 1994, 30, 397–421.CrossRefGoogle Scholar
3.Berbatis, C. G., Nager, N. H., Plumridge, R. J., et al. Impact of a drug bulletin on prescribing oral analgesics in a teaching hospital. American Journal of Hospital Pharmacy, 1982, 38, 98–100.Google Scholar
4.Brudon-Jakobowicz, P., Rainhorn, J.-D., & Reich, M. R.Indicators for monitoring national drug policies: A practical manual. Geneva: World Health Organization, 1994.Google Scholar
5.Chambers, L. W., Sibley, J. C., Spitzer, W. O., & Tugwell, P.Quality of care assessment: How to set up and use an indicator condition. Clinical and Investigative Medicine, 1981, 4, 41–50.Google ScholarPubMed
6.Chitanondh, H. Communication for control of tobacco use. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 32–36.Google Scholar
7.Escarce, J. J., Chen, W., & Schwartz, S.Falling cholecystectomy thresholds since the introduction of laparoscopic cholecystectomy. Journal of the American Medical Association, 1995, 273, 1581–85.CrossRefGoogle ScholarPubMed
8.Green, A., & Barker, C.Priority setting and economic appraisal: Whose priorities — The community or the economist? Social Sciences and Medicine, 1988, 26, 919–29.CrossRefGoogle ScholarPubMed
9.Guyatt, G. H., Sackett, D. L., & Cook, D. J.Users’ guides to the medical literature, II: How to use an article about therapy or prevention, A: Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 1993, 270, 2598–601.CrossRefGoogle Scholar
10.Hadorn, D. C.The problem of discrimination in health care priority setting. Journal of the American Medical Association, 1992, 268, 1454–59.CrossRefGoogle ScholarPubMed
11.Hansagi, H., Edhag, O., & Allebeck, P.High consumers of health care in emergency units: How to improve their quality of care [review]. Quality Assurance in Health Care, 1991, 3, 51–62.CrossRefGoogle ScholarPubMed
12.Haynes, R. B., McKibbon, K. A., Fitzgerald, D., et al. How to keep up with the medical literature, III: Expanding the number of journals you read regularly. Annals of Internal Medicine, 1986, 105, 474–78.CrossRefGoogle ScholarPubMed
13.Haynes, R. B., McKibbon, K. A., Fitzgerald, D., et al. How to keep up with the medical literature, IV: Using the literature to solve clinical problems. Annals of Internal Medicine, 1986, 105, 636–40.CrossRefGoogle ScholarPubMed
14.Haynes, R. B., McKibbon, K. A., Fitzgerald, D., et al. How to keep up with the medical literature, V: Access by personal computer to the medical literature. Annals of Internal Medicine, 1986, 105, 810–16.CrossRefGoogle ScholarPubMed
15.Hogerzeil, H. V., Walker, G. J. A., Sallam, A. O., & Fernando, G.Impact of an essential drugs programme on availability and rational use of drugs. Lancet, 1989, i, 14.Google Scholar
16.Houpjaroen, S. Communication for rational use of drugs: The experiences of the Food and Drug Administration. In Ngamvithayapongse, J. (ed.), Communication to Promote Rational Use of Drugs. Bangkok: Chulalongkorn University Printing House, 1994, 99–104.Google Scholar
17.Jaeschke, R., Guyatt, G., & Sackett, D. L.Users' guides to the medical literature, III: How to use an article about a diagnostic test, A: Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 1994, 271, 389–91.CrossRefGoogle Scholar
18.Jaeschke, R., Guyatt, G. H., & Sackett, D. L.Users' guides to the medical literature, III: How to use an article about a diagnostic test, B: What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. Journal of the American Medical Association, 1994, 271, 703–07.CrossRefGoogle Scholar
19.Kiatying-Angsulee, N.Double standard labelling of pharmaceuticals sold in Thailand. Short Communication. Bangkok: The Faculty of Pharmacy, Chulalongkorn University, 1990.Google Scholar
20.Kittiwongsoontorn, V. Communication for rational use of drugs: The experience of the provincial chief medical office. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 92–95.Google Scholar
21.Klein, R.Dimensions of rationing: Who should do what? British Medical Journal, 1993, 307, 309–11.CrossRefGoogle Scholar
22.Kulsomboon, V. Drug use problems in Thailand and communication for rational use of drugs. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 55–58.Google Scholar
23.Laupacis, A., Wells, G., Richardson, W. S., & Tugwell, P.Users' guides to the medical literature, V: How to use an article about prognosis. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 1994, 272, 234–37.CrossRefGoogle Scholar
24.Lazaro, P., & Fitch, K.The distribution of ‘big ticket’ medical technologies in OECD countries. International Journal of Technology Assessment in Health Care, 1995, 3, 552–70.CrossRefGoogle Scholar
25.Lexchin, J.Doctors and detailers: Therapeutic education or pharmaceutical promotion? International Journal of Health Services, 1989, 19, 663–79.Google Scholar
26. Melatonin needs to be registered. Bangkok: Bangkok Post Newspaper, 1996, 05 17.Google Scholar
Internet Thailand Service Center and NECTEC Information, Bangkok: The Office of the Prime Minister, 1996.Google Scholar
27.Mugford, M., Banfield, P., & O'Hanlon, M.Effects of feedback of information on clinical practice: A review. British Medical Journal, 1990, 303, 398–402.CrossRefGoogle Scholar
28.Murray, C. J.Rational approaches to priority setting in international health. Journal of Tropical Medicine and Hygiene, 1990, 93, 303–11.Google ScholarPubMed
29.National Statistical Office. Population and housing census, 1990. Bangkok: Government Printing House, 1996.Google Scholar
30.Ngamvithayapongse, J. (ed.). Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994.Google Scholar
31.Ngamvithayaponse, J. (ed.). The role of pharmacoepidemiology in rational use of drugs in Thailand. Bangkok: Chulalongkorn University Printing House, 1994.Google Scholar
32.Oxman, A. D., Sackett, D. L., & Guyatt, G. H.Users' guides to the medical literature, I: How to get started. The Evidence-Based Medicine Working Group. Journal of the American Medical Association, 1993, 270, 2093–95.Google Scholar
33. Pharmaceutical products summary of competitive advertising. Media Focus, 1992.Google Scholar
34.Pradubmook, P. The situations of drugs and drug revolving funds in rural communities. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 59–61.Google Scholar
35.Riewpitak, D. Communication for rational use of drugs: The experiences of UNESCO regional office for Asia and the Pacific. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 109.Google Scholar
36.Sakala, C.Medically unnecessary caesearean section birth: introduction to a symposium. Social Science and Medicine, 1993, 37, 1177–93.CrossRefGoogle Scholar
37.Schaffner, W., Ray, W. A., Federspiel, C. F. & Miller, W. O.Improving antibiotic prescribing in office practice. Journal of the American Medical Association, 1983, 250, 1728–32.CrossRefGoogle ScholarPubMed
38.Smart, R. G., & Fejer, D.Drug education: Current issues, future directions. Toronto: Addiction Research Foundation of Ontario, 1974, 1–112.Google Scholar
39.Soumerai, S., Quick, J., Avorn, J., & Tawfik, Y.Changing the unchangable. World Paediatrics and Child Care, 1987, 3, 287–91.Google Scholar
40.Supachutikul, A.Management of medical and health technology. Bangkok: Health System Research Institute, 1996, 1–65.Google Scholar
41.Tangcharoensatien, V.The distribution of medical equipment in Thailand. Bangkok: Health System Research Institute, 1995 (unpublished).Google Scholar
42.Tangcharoensatien, V.The distribution and cost effectiveness of lithotripsy in Thailand. Bangkok: Health System Research Institute, 1994 (unpublished).Google Scholar
43.Tangcharoensatien, V. Advertisements of food, drugs, cosmetics and other technologies. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 66–73.Google Scholar
44.Thailand Health Research Institute. Thai drug system: A situation analysis for further development. Bangkok: Thailand Health Research Institute, 1995.Google Scholar
45.Thomson, R., Lavender, M., & Madhok, R.How to ensure that guidelines are effective [review]. British Medical Journal, 1995, 311, 237–42.CrossRefGoogle ScholarPubMed
46.Tuiyathan, S. The role of private advertising company in the development of the health of the public. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 37–44.Google Scholar
47.Turek, F. W.Melatonin hype hard to swallow. Nature, 1996, 379, 295–96.CrossRefGoogle Scholar
48.Valbunena, V. Communication theory: Some applications to health-related communication behavior. In Finer, D. & Tomson, G. (eds.), Essential drug information: The story of a workshop. Stockholm: REPRO PRINT AB, 1992, 63–78.Google Scholar
49.Veera-anantavatn, P. Communication for rational use of drugs: The experiences of provincial hospitals. In Ngamvithayapongse, J. (ed.), Communication for rational use of drugs. Bangkok: Chulalongkorn University Printing House, 1994, 89–91.Google Scholar